Codexis Stock

Codexis FCF/Net Income

The Free Cash Flow to Net Income Ratio of Codexis (CDXS) as of Aug 23, 2026 is 54.23 %. In the previous year, Free Cash Flow to Net Income Ratio was 82.29 % — a change of -34.10% (lower).

FCF/Net Income

54.23 %

YoY

-34.10%

Last updated:

Free Cash Flow to Net Income Ratio of Codexis is 2026 54.23 % . Free Cash Flow to Net Income Ratio of Codexis was 2025 82.29 % . It decreases by -34.10% lower compared to the previous year.

The Codexis FCF/Net Income history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF/Net Income
Date
FCF/Net Income
Jan 1, 2018
155.01 USD
Jan 1, 2019
136.49 USD
Jan 1, 2020
84.18 USD
Jan 1, 2021
132.03 USD
Jan 1, 2022
-8.86 USD
Jan 1, 2023
74.84 USD
Jan 1, 2024
82.29 USD
Jan 1, 2025
54.23 USD
The Codexis FCF/Net Income history
YEARFCF/Net IncomeYoY
54.23 %-34.10%
82.29 %+9.96%
74.84 %-944.45%
-8.86 %-106.71%
132.03 %+56.84%
84.18 %-38.32%
136.49 %-11.95%
155.01 %+265.68%
42.39 %+1.08%
41.94 %+94.81%
21.53 %-21,707.95%
-0.10 %
Access this data via the Eulerpool API

Codexis Stock analysis

What does Codexis do? Codexis Inc. is an American biotechnology company that specializes in developing innovative biological solutions for a variety of industries. The company was founded in 2002 and is headquartered in Redwood City, California. Business Model: Codexis is service-oriented and provides customized enzyme solutions for companies looking to improve their products through sustainable processes. The company has developed a unique platform called Rational Protein Engineering, which allows for the development of specific enzymes for various industries. Customers benefit from enzyme optimization expertise and know-how. Divisions: Codexis operates in the fields of life sciences, materials science, agrochemicals, and biofuels. 1. Life Sciences: Codexis specializes in the production of enzymes and biocatalysts for the pharmaceutical industry in the life sciences division. The goal is to provide a faster and more efficient manufacturing process for pharmaceutical active ingredients. The company has successfully developed active ingredients for antibodies, lipids, uric acid, and antivirals. 2. Materials Science: In the materials science division, Codexis specializes in the production of enzymes for materials such as dyes, polymers, and cosmetic products. Codexis ensures that these products are efficiently manufactured without the use of environmentally harmful chemicals. 3. Agrochemicals: Codexis offers customized enzyme solutions to agrochemical manufacturers that reduce the use of chemicals and benefit the environment. These enzymes help in the production of pesticides and other agrochemicals. 4. Biofuels: In the biofuels division, Codexis specializes in the production of enzymes for processing corn, harvested plants, or waste products. These enzymes help enable cost-effective biofuel production. Products: Codexis has developed a wide range of products tailored to the needs of various industries. Some of the products recently introduced to the market by Codexis include: 1. CodeEvolver: CodeEvolver is a platform that allows biotechnology companies to quickly create customized enzyme solutions for their specific needs. The process is fully automated and results in a significant reduction in development time and costs. 2. Codex® screening panels: Codexis offers various screening panels that allow customers to quickly and efficiently select the enzymes best suited for their purposes. The panels are suitable for industries including pharmaceuticals, chemicals, and plant protection. 3. Codex® enzymes: Codexis offers a wide range of enzymes specifically designed for different industry needs. This includes enzymes for the production of biofuels, pesticides, cosmetic products, and pharmaceuticals. Overall, Codexis Inc. has demonstrated its ability to deepen the understanding of biocatalysts and introduce innovative biological processes in a variety of industries through its unique Rational Protein Engineering platform. Codexis is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Codexis stock

Free Cash Flow to Net Income Ratio of Codexis is 54.23 % in 2026.

Free Cash Flow to Net Income Ratio of Codexis changed from 82.29 % to 54.23 %, representing a -34.10% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow to Net Income Ratio Codexis since 2006 – with annual values, charts, and detailed analysis.

The FCF/Net Income ratio measures cash flow quality. Ratios consistently above 100% suggest high-quality earnings with strong cash backing.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow to Net Income Ratio's Codexis with sector peers and the industry average to assess whether it is attractive.

To evaluate Free Cash Flow to Net Income Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow to Net Income Ratio.

Access this data via the Eulerpool API

Cash Flow — Codexis

All Key Metrics — Codexis